Patients Discontinuing Anti-Obesity Injections Put On Pounds Far More Rapidly Compared to Dieters

Fresh analysis reveals that people who stop using new slimming jabs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who end conventional diet and exercise regimens.

Published data in a major health publication demonstrates that while obese individuals can lose about a fifth of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month once they quit.

"Individuals purchasing these treatments should be aware of the potential of quick weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.

This pace of regain means a return to starting weight within about 18 months.

Weighing Treatments

The study, which looked at 37 of studies involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with older methods.

Scientists point out that people who shed pounds through lifestyle changes alone typically experience a more gradual creep back—around 100 grams monthly—after stopping.

Understanding the Fast Rebound

Doctors believe the way of the injections is key to understanding the amplified rebound.

The injections imitate a body's own chemical called GLP-1, which moderates appetite.

"Sustained high doses of GLP-1 levels far above than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this hormone supplement leads to appetite is no longer kept in check, making overeating much more probable."

A Lifelong Condition?

Medical guidelines advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.

A number of clinicians contend that, considering the significant potential of relapse, the treatment might need to be long-term.

This opinion is reinforced by drug manufacturers, who state that the findings "underscore the long-term nature of obesity," comparing it to managing diseases like diabetes.

User Accounts

People who have stopped the jabs describe a sudden return of appetite.

"It was like a trigger that goes on and you become starving," recalled an individual.

This challenge is worsened if individuals have not adopted sustainable lifestyle or habit changes during therapy.

Widespread Interest

Survey data suggest that a significant number of adults in the UK have tried these injections in the past year, with desire continuing to grow.

• Use is higher among women compared to men.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion obtain the medications through private healthcare rather than public health services.

Finally, experts caution that while these medications are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on combined lifestyle support.